13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442756
Total reported value
$1.2B
$1.2B
56 檔
38.5%
At the close of Q2 2025, PFM Health Sciences, LP disclosed equity holdings valued at approximately $1.2B, spread across 56 reported holdings.
In Q2 2025, PFM Health Sciences, LP adopted a defensive or profit-taking posture, trimming 23 positions and completely liquidating 26 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including LLY, THC, MCK) accounted for 38.5% of total reported equity market value during Q2 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 17.79% | -1.48% | -2.10% | |
| 2 | THC | Tenet Healthcare CORP | Stock-Healthcare | 7.48% | -4.83% | +1.61% | |
| 3 | MCK | Mckesson CORP | Stock-Healthcare | 4.51% | — | -25.83% | |
| 4 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 4.29% | +0.54% | -13.20% | |
| 5 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 4.12% | — | -4.41% | |
| 6 | PEN | Penumbra Inc | Stock-Healthcare | 3.63% | -2.56% | — | |
| 7 | ASND | Ascendis Pharma A/S | Stock-Other | 3.26% | -3.64% | EXIT | |
| 8 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 2.90% | -0.76% | EXIT | |
| 9 | CVS | Cvs Health CORP | Stock-Healthcare | 2.81% | +1.22% | NEW | |
| 10 | OM | Outset Medical Inc | Stock-Other | 2.72% | +0.01% | -1.25% | |
| 11 | DHR | Danaher CORP | Stock-Healthcare | 2.71% | — | +43.51% | |
| 12 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.65% | +1.72% | +177.47% | |
| 13 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 2.61% | +0.08% | +3.30% | |
| 14 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | Bond | 2.46% | -1.54% | EXIT | |
| 15 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.36% | -0.49% | -6.68% | |
| 16 | HUM | Humana Inc | Stock-Healthcare | 2.28% | +3.22% | NEW | |
| 17 | MOH | Molina Healthcare Inc | Stock-Healthcare | 2.17% | — | +22.33% | |
| 18 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 2.00% | — | -17.13% | |
| 19 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 1.92% | -0.13% | -42.54% | |
| 20 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.77% | — | — | |
| 21 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 1.70% | — | +16.91% | |
| 22 | NTRA | Natera Inc | Stock-Healthcare | 1.46% | -0.58% | — | |
| 23 | COR | Cencora Inc | Stock-Healthcare | 1.36% | +0.86% | NEW | |
| 24 | MASI* | Masimo CORP | Stock-Other | 1.35% | — | — | |
| 25 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 1.34% | +0.75% | -14.61% | |
| 26 | WAT | Waters CORP | Stock-Healthcare | 1.28% | +0.85% | -16.91% | |
| 27 | AKRO | Akero Therapeutics Inc | Stock-Other | 1.21% | — | — | |
| 28 | HO1 | Hologic Inc | Stock-Other | 1.18% | — | — | |
| 29 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 1.16% | +0.67% | NEW | |
| 30 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 1.10% | +0.54% | NEW | |
| 31 | ICLR | ICON Public Limited Company | Stock-Healthcare | 1.09% | +1.45% | +114.88% | |
| 32 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.90% | — | — | |
| 33 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.89% | -4.03% | — | |
| 34 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 0.83% | — | — | |
| 35 | ✓ | Merus N V | Stock-Other | 0.82% | — | — | |
| 36 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.65% | — | — | |
| 37 | ABBV | Abbvie Inc | Stock-Healthcare | 0.64% | — | -87.71% | |
| 38 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.53% | — | +4.29% | |
| 39 | NEO | Neogenomics Inc | Stock-Healthcare | 0.48% | -1.21% | EXIT | |
| 40 | CMPS | Compass Pathways PLC | Stock-Other | 0.42% | -0.39% | +294.28% | |
| 41 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 0.40% | +0.04% | -12.21% | |
| 42 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.39% | -1.91% | EXIT | |
| 43 | ARGX | Argenx Se - Adr | Stock-Healthcare | 0.34% | +0.06% | -89.51% | |
| 44 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.30% | +0.07% | -47.34% | |
| 45 | INBX | Inhibrx Biosciences Inc | Stock-Other | 0.30% | +0.64% | -44.40% | |
| 46 | IOBTQ | Io Biotech Inc | Stock-Other | 0.23% | — | -15.76% | |
| 47 | QURE | uniQure N.V. | Stock-Other | 0.21% | +0.04% | -70.94% | |
| 48 | RZLT | Rezolute Inc | Stock-Other | 0.16% | +0.02% | — | |
| 49 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.15% | -0.12% | -45.79% | |
| 50 | IRON | Disc Medicine Inc | Stock-Other | 0.14% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | THC | Tenet Healthcare CORP | +2.7% | +1.61% | Add |
| 2 | TEVA | Teva Pharmaceutical-sp Adr | +1.8% | NEW | New buy |
| 3 | NTRA | Natera Inc | +1.5% | NEW | New buy |
| 4 | LLY | Eli Lilly & Co | +1.4% | -2.10% | Trim |
| 5 | OM | Outset Medical Inc | +1.4% | -1.25% | Trim |
| 6 | COR | Cencora Inc | +1.4% | NEW | New buy |
| 7 | MASI* | Masimo CORP | +1.4% | NEW | New buy |
| 8 | UNH | Unitedhealth Group Inc | +1.3% | +177.47% | Add |
| 9 | CVS | Cvs Health CORP | +1.3% | +53.38% | Add |
| 10 | AKRO | Akero Therapeutics Inc | +1.2% | NEW | New buy |
| 11 | HO1 | Hologic Inc | +1.2% | NEW | New buy |
| 12 | IRTC | Irhythm Holdings Inc | +1.2% | NEW | New buy |
| 13 | ASND | Ascendis Pharma A/S | +1.1% | +18.64% | Add |
| 14 | ARQT | Arcutis Biotherapeutics Inc | +1.1% | NEW | New buy |
| 15 | HUM | Humana Inc | +1.1% | +73.17% | Add |
| 16 | DHR | Danaher CORP | +1% | +43.51% | Add |
| 17 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.9% | NEW | New buy |
| 18 | INDV | Indivior Pharmaceuticals, Inc. | +0.9% | +16.91% | Add |
| 19 | UTHR | United Therapeutics CORP | +0.9% | NEW | New buy |
| 20 | BMRN | Biomarin Pharmaceutical Inc | +0.8% | NEW | New buy |
| 21 | ✓ | Merus N V | +0.8% | NEW | New buy |
| 22 | ISRG | Intuitive Surgical Inc | +0.8% | -4.41% | Trim |
| 23 | VRNA | Verona Pharma PLC - Adr | +0.7% | NEW | New buy |
| 24 | EW | Edwards Lifesciences CORP | +0.6% | +3.30% | Add |
| 25 | ICLR | ICON Public Limited Company | +0.6% | +114.88% | Add |
| 26 | OSCR | Oscar Health Inc - Class A | +0.5% | -14.61% | Trim |
| 27 | MOH | Molina Healthcare Inc | +0.5% | +22.33% | Add |
| 28 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | +0.5% | — | Unchanged |
| 29 | HCA | Hca Healthcare Inc | +0.4% | -6.68% | Trim |
| 30 | PEN | Penumbra Inc | +0.4% | — | Unchanged |
| 31 | CMPS | Compass Pathways PLC | +0.3% | +294.28% | Add |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | +0.3% | -17.13% | Trim |
| 33 | 2655787D | Blueprint Medicines CORP | +0.2% | +4.29% | Add |
| 34 | AMLX | Amylyx Pharmaceuticals Inc | +0.2% | -12.21% | Trim |
| 35 | RZLT | Rezolute Inc | +0.2% | NEW | New buy |
| 36 | IRON | Disc Medicine Inc | +0.1% | NEW | New buy |
| 37 | NBIX | Neurocrine Biosciences Inc | +0.1% | NEW | New buy |
| 38 | VKTX | Viking Therapeutics Inc | +0.1% | NEW | New buy |
| 39 | NEO | Neogenomics Inc | +0.1% | +31.54% | Add |
| 40 | GPCR | Structure Therapeutics Inc | +0.1% | +40.08% | Add |
| 41 | IOBTQ | Io Biotech Inc | 0% | -15.76% | Trim |
| 42 | CRBU | Caribou Biosciences Inc | 0% | -45.79% | Trim |
| 43 | IOVA | Iovance Biotherapeutics Inc | 0% | EXIT | Sold out |
| 44 | ✓ | Turnstone Biologics CORP | 0% | EXIT | Sold out |
| 45 | BOLD | Boundless Bio Inc | 0% | EXIT | Sold out |
| 46 | CELC | Celcuity Inc | 0% | EXIT | Sold out |
| 47 | ✓ | Verve Therapeutics Inc | -0.1% | EXIT | Sold out |
| 48 | ACLXGBX | Arcellx Inc | -0.1% | EXIT | Sold out |
| 49 | SWTXUSD | Springworks Therapeutics Inc | -0.1% | EXIT | Sold out |
| 50 | KROS | Keros Therapeutics Inc | -0.1% | EXIT | Sold out |
According to official SEC Form 13F filings, PFM Health Sciences, LP reported a total U.S. public equity portfolio value of $1.2B across 56 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
TEVA
市值: $20.8M
Top Position Liquidated / Trimmed
XLV
前期市值: $62.7M
During Q2 2025, PFM Health Sciences, LP's top holdings by market value included LLY (17.8%)、THC (7.5%)、MCK (4.5%). The largest single position, LLY, represented 17.8% of total portfolio value.
In Q2 2025, PFM Health Sciences, LP made 80 total portfolio adjustments, initiating 17 new buys, adding to 14 positions, trimming 23 holdings, and fully liquidating 26 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.